← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:851 | 851 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:851 | 851 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:851 | 851 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0850 | 5446-0850-10 | Lidocaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-06 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:851 | 851 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6310 | 72682-6310-1 | Methylcobalamin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:851 | 851 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:851 | 851 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:852 | 852 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-001 | 72055-001-01 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-538 | 69374-538-03 | Methacholine Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0425 | 71285-0425-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:852 | 852 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-28 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:852 | 852 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:853 | 853 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3020 | 79559-3020-1 | S-E020 | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:853 | 853 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-06 | Labetalol Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:853 | 853 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:853 | 853 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3020 | 71286-3020-1 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6305 | 72682-6305-1 | Methylcobalamin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-536 | 69374-536-50 | Methacholine Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0430 | 71285-0430-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:853 | 853 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:854 | 854 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-589 | 69194-589-01 | 589 LIDOCAINE HCl 1%, PHENYLEPHRINE HCl 1.5% VIAL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:854 | 854 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:854 | 854 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:854 | 854 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:854 | 854 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:854 | 854 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-539 | 69374-539-03 | Methacholine Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1075 | 71266-1075-1 | Methylprednisolone Acetate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:854 | 854 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:855 | 855 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:855 | 855 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:855 | 855 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:855 | 855 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:855 | 855 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:855 | 855 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-537 | 69374-537-03 | Methacholine Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0027 | 81483-0027-1 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1020 | 73013-1020-1 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:855 | 855 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:856 | 856 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1050 | 73271-1050-1 | TESTOSTERONE 50 PEL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-946 | 69374-946-04 | Labetalol Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Leflunomide | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1223 | 70657-1223-3 | Methylcobalamin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-540 | 69374-540-03 | Methacholine Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:856 | 856 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:856 | 856 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:857 | 857 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | BUTT BALM | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:857 | 857 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:857 | 857 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:858 | 858 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8241 | 71266-8241-5 | Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 10%, Ketorolac 0.5% | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2415 | 72627-2415-1 | Levocarnitine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5588 | 26436-5588-1 | Methylcobalamin | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:858 | 858 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5629 | 26436-5629-1 | Naltrexone Hydrochloride Dihydrate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:858 | 858 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:859 | 859 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-304 | 68985-304-92 | VANCOMYCIN 1.25G | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2415 | 72627-2415-1 | Levocarnitine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-5974 | 72682-5974-3 | Lysine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:859 | 859 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:859 | 859 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:860 | 860 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-0 | NAD | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:860 | 860 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:860 | 860 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:860 | 860 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:860 | 860 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-30 | Methionine; Cyanocobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2417 | 72627-2417-1 | Lysine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0026 | 81483-0026-0 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:860 | 860 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:860 | 860 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:861 | 861 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-107 | 73702-107-15 | Ephedrine Sulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-1 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-10 | Methionine; Cyanocobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5080 | 26436-5080-3 | Lysine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-30 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-129 | 69194-129-01 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:861 | 861 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:861 | 861 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:862 | 862 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-0 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-3 | Methionine; Inositol; Choline Chloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8020 | 71266-8020-1 | Lysine Hydrochloride; Arginine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-130 | 69194-130-01 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:862 | 862 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:862 | 862 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2547 | 72934-2547-2 | Niacinamide; Azelaic Acid | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:863 | 863 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Trophamine 3.5% / Dextrose 10% 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1011 | 71283-1011-5 | Lidocaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0002 | 81483-0002-0 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylprednisolone Acetate; Lidocaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2022-2 | valid | 0 | 2026-10-17 |